Informing the development of antipsychotic-induced weight gain management guidance: patient experiences and preferences - qualitative descriptive study

被引:2
|
作者
Fitzgerald, Ita [1 ,2 ]
Crowley, Erin K. [2 ]
Ni Dhubhlaing, Ciara [1 ,3 ]
O'Dwyer, Sarah [4 ]
Sahm, Laura J. [2 ,5 ]
机构
[1] St Patricks Mental Hlth Serv, Pharm Dept, Dublin, Ireland
[2] Univ Coll Cork, Sch Pharm, Pharmaceut Care Res Grp, Cork, Ireland
[3] Coll Mental Hlth Pharm, Burgess Hill, England
[4] St Patricks Mental Hlth Serv, Dept Med, Dublin, Ireland
[5] Mercy Univ Hosp, Pharm Dept, Cork, Ireland
来源
BJPSYCH OPEN | 2024年 / 10卷 / 05期
关键词
Antipsychotics and antipsychotic-induced weight gain; schizophrenia; health services research; guideline; patient preferences; GUIDELINES; OBESITY; SCHIZOPHRENIA; STIGMA; HEALTH;
D O I
10.1192/bjo.2024.725
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Antipsychotic-induced weight gain (AIWG) is a substantial contributor to high obesity rates in psychiatry. Limited management guidance exists to inform clinical practice, and individuals with experience of managing AIWG have had no or minimal input into its development. A lack of empirical research outlining patient values and preferences for management also exists. Recommendations addressing weight management in psychiatry may be distinctly susceptible to ideology and sociocultural values regarding intervention appropriateness and expectations of self-management, reinforcing the need for co-produced management guidance. This study is the first to ask: how do individuals conceptualise preferred AIWG management and how can this be realised in practice?Aims 1. Explore the management experiences of individuals with unwanted AIWG. 2. Elicit their values and preferences regarding preferred management.Method Qualitative descriptive methodology informed study design. A total of 17 participants took part in semi-structured interviews. Data analysis was undertaken using reflexive thematic analysis.Results Participants reported that clinicians largely overestimated AIWG manageability using dietary and lifestyle changes. They also reported difficulties accessing alternative management interventions, including a change in antipsychotic and/or pharmacological adjuncts. Participants reported current management guidance is oversimplified, lacks the specificity and scope required, and endorses a 'one-size-fits-all' management approach to an extensively heterogenous side-effect. Participants expressed a preference for collaborative AIWG management and guidance that prioritises early intervention using the range of evidence-based management interventions, tailored according to AIWG risk, participant ability and participant preference.Conclusion Integration of this research into guideline development will help ensure recommendations are relevant and applicable, and that individual preferences are represented.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Metformin in the management of antipsychotic-induced weight gain - why the 'weight'?
    Fitzgerald, Ita
    Sahm, Laura J.
    Ni Dhubhlaing, Ciara
    O'Dwyer, Sarah
    O'Connell, Jean
    Torrens, Jennifer
    Crowley, Erin K.
    FRONTIERS IN PSYCHIATRY, 2024, 15
  • [2] Role of metformin in the management of antipsychotic-induced weight gain
    Prajapati, Asta R.
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2014, 18 (06) : 33 - 38
  • [3] Behavioural management of antipsychotic-induced weight gain: a review
    Werneke, U
    Taylor, D
    Sanders, TA
    Wessely, S
    ACTA PSYCHIATRICA SCANDINAVICA, 2003, 108 (04) : 252 - 259
  • [4] Pharmacological Management of Atypical Antipsychotic-Induced Weight Gain
    Trino Baptista
    Yamily ElFakih
    Euderruh Uzcátegui
    Ignacio Sandia
    Eduardo Tálamo
    Enma Araujo de Baptista
    Serge Beaulieu
    CNS Drugs, 2008, 22 : 477 - 495
  • [5] Pharmacological management of atypical antipsychotic-induced weight gain
    Baptista, Trino
    ElFakih, Yamily
    Uzcategui, Euderruh
    Sandia, Ignacio
    Talamo, Eduardo
    de Baptista, Enma Araujo
    Beaulieu, Serge
    CNS DRUGS, 2008, 22 (06) : 477 - 495
  • [6] MANAGEMENT OF ANTIPSYCHOTIC-INDUCED WEIGHT GAIN IN THE PRIMARY CARE SETTING
    Ganguly, Anisha
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S368 - S369
  • [7] A naturalistic study of antipsychotic-induced weight gain in bipolar disorder
    Najar, H.
    Palsson, E.
    Landen, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S438 - S439
  • [8] Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate
    Lin, YH
    Liu, CY
    Hsiao, MC
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 59 (05) : 613 - 615
  • [9] Contingency Management for the Treatment of Antipsychotic-Induced Weight Gain: A Randomized Controlled Pilot Study
    Ratliff, Joseph C.
    Palmese, Laura B.
    Tonizzo, K. Melek
    Chwastiak, Lydia
    Tek, Cenk
    OBESITY FACTS, 2012, 5 (06) : 919 - 927
  • [10] Pilot Trial of Contingency Management For the Treatment of Antipsychotic-Induced Weight Gain
    Ratliff, Joseph C.
    Palmese, Laura B.
    Tonizzo, Kamile M.
    Reutenauer, Erin L.
    Tek, Cenk
    OBESITY, 2011, 19 : S99 - S100